AUS
NZ
UK
CA
USA
IND
_02_06_2025_07_05_23_538703.jpg)
Shares of Helia Group Ltd (ASX: HLI) experienced a robust rebound on Thursday, surging nearly 16% to AU$3.865 per share on the ASX 200. This recovery comes after a sharp sell-off triggered by reports that Commonwealth Bank of Australia (ASX: CBA) was initiating a tender for its lenders mortgage insurance (LMI) business, a long-standing contract with Helia.
Just the day before, Helia had closed at AU$4.22 per share, only to plummet to AU$3.34 per share amidst investor anxiety over the potential loss of the lucrative CBA contract, which currently contributes about 53% of Helia's gross written premium (GWP).
Today's resurgence in Helia's stock price follows an upgrade from analysts at Macquarie, injecting renewed optimism into the market sentiment surrounding the company. Macquarie's analysts have indicated confidence that Helia is well-positioned to retain the CBA tender, citing the company's historical success in similar situations.
"We think HLI would likely win the tender again and be the exclusive LMI writer for CBA," Macquarie noted in a research note, emphasizing Helia's track record and strategic positioning.
The potential ramifications of losing the CBA contract appear to be minimal in the short term, according to Macquarie's analysis. The current contract runs until the end of 2025, with any revenue impacts not anticipated until 2027. Furthermore, Macquarie believes that winning the tender could also open opportunities with Bankwest, potentially boosting Helia's GWP by 9%.
Goldman Sachs also weighed in on the situation, highlighting that this is not the first time Helia's contract with CBA has been subject to a request for proposal (RFP) process. Despite the uncertainty, Goldman Sachs maintains a neutral rating on Helia's stock with a price target of AU$4.53 per share, suggesting a cautious but steady outlook.
"We note that this is the second time in three years that HLI's Supply and Service contract with CBA has been put up for RFP," Goldman Sachs stated in its analysis, indicating a recurring challenge that Helia has navigated successfully in the past.
Both Macquarie and Goldman Sachs agree that Helia has enhanced its technological integration with CBA, which could strengthen its position in the upcoming tender process.
Today's market reaction underscores investor vigilance regarding the outcome of the CBA tender. Despite recent volatility, Helia's shares have managed to retain a 13% gain over the last 12 months, reflecting resilience amidst operational challenges and market fluctuations.
